Distances and angles of the hydrogen bonds in the paracetamol polymorphs.
1. Introduction
Crystallization, commonly defined as a process of formation of a crystalline solid from a supersaturated solution, melt or vapor phase, is an old technique widely used in laboratory and in industrial processes to separate and purify substances. In various modern industries, crystalline forms with a certain habit, size and structure, constitute the basic materials for the production of highly sophisticated materials [1, 2]. Integrated circuits as well as piezoelectric and optical materials are just a few examples of devices whose properties are dependent on the crystal structure. Also, in organic chemistry, molecular crystals with determined characteristics are now-a-days of utmost importance for the production of pharmaceuticals, dyestuffs, pigments, foodstuffs, chemicals, cosmetics, etc. For all these reasons, crystal growth has become an important and attractive research field.
Crystallization from solution is one of the preferred methods to obtain a crystal since it can be carried out under different experimental conditions and provides a wide variety of products. In fact, it can occur by lowering the temperature of a supersaturated solution, partial evaporation of the solvent, precipitation by adding an anti-solvent or vapor diffusion of a gas into the solution. Furthermore, solvents with different properties can be used. Such a diversity of experimental conditions has great influence in the output,
The various steps of crystallization from solvents are summarized in the following scheme:

Scheme 1.
Main crystallization pathways from solution
The competition between the solute-solvent and solute-solute interactions to form the nuclei, and between the specific aggregation forces and packing in order to minimize repulsive interactions, determine the structure of the new crystalline phase. During this process the molecular conformation can change drastically in an unpredicted way. Various computational approaches have been employed to predict the crystalline structure (unit cell, space group and atomic coordinates) formed by a given molecule [6-8], most of them relying on the assumption that the most probable forms are those with lowest lattice energy. Despite the recent success of these methods in the prediction of crystalline structures of small rigid molecules [9], their applicability to high size flexible molecules is not yet satisfactory [10, 11]. The main drawbacks lie in the difficultly of describing accurately the high complexity of inter and intramolecular interactions (e.g. hydrogen bonds and van der Waals interactions) and of selecting, among the energetically feasible polymorphs, that or those that really exist [3]. In truth, crystal prediction is still a very hard task so far.
Nevertheless, computational calculation can be a powerful tool to get information about the different steps of crystallization. The main goal of the present chapter is included in this research field. Quantum-chemical calculations or molecular dynamics simulations, adapted to the molecular complexity can be used for this purpose. In molecular terms, a compound with a certain conformational flexibility exists in a supersaturated aqueous solution as a mixture of conformers with different populations. The knowledge of the conformational equilibrium in this medium is a way of identifying the conformers that are likely to be involved in the early stages of nucleation and to interpret the mechanism of the crystallization process. In this chapter, these topics are addressed by presenting the results obtained for erythritol and
As crystallization proceeds, the self-association of the solute molecules gives rise to molecular aggregates which play an important role in the resulting crystalline structure [23-25]. Data from the application of molecular dynamics simulations in the study of aqueous solutions of erythitol and
As stated before, depending on the experimental conditions and intrinsic molecular features of the molecules, different crystalline phases or polymorphs can be obtained by crystallization. The polymorphs differ from one another in the arrangement (packing) and/or conformation of the molecules in the crystal lattice [26-29]. They are commonly called packing polymorphs in the first case and conformational polymorphs in the second one. Polymorphism has significant implications in a wide range of areas and for this reason it has been matter of extensive investigation. Some typical examples are here reported with the objective of pointing out the diversity of structures that can obtained by crystallization.
2. Nucleation and crystal growth
Fluctuations of the order of a solution, for example density, are accompanied by the formation of solute molecular clusters. The driving force to bring the molecules close together is given by the following chemical potential difference:
In this equation,
where
With the increase of concentration, the amplitude of the fluctuations also increase and so do the size of the clusters. For smaller size clusters, Δ
where Δgc corresponds to the value of Δg at
Combining (4c) and (5), the following expression is obtained for Δ
Δ
This equation shows that the rate of nucleation is strongly dependent on the supersaturation and tends to a finite value for a given supersaturation.

Figure 1.
Variation of ∆g and its components with the radius of the molecular clusters.
Organic crystals are supramolecules,
It is obvious that a crystal packing in which the specific interactions between the functional groups (molecular recognition) are more favorable is, in principle, that leading to the lowest energy. Thus, the lowest energy crystalline structure would correspond to the stronger interaction between a group and its complementar in nature. For example, to a positive charge there would be a negative one, or to a H-bond donor a H-bond acceptor. The molecular packing bringing the molecules close together also gives rise to steric repulsion. Hence, the equilibrium structure is the result between the attraction force and the steric repulsion. This compromise makes the molecule to adopt a conformation corresponding to the lowest Gibbs energy.
Let us consider the conformational variation from the gas phase to the solid for a simple molecule as paracetamol (acetaminophen). This is a drug of great commercial interest in the pharmaceutical industry owing to its wide use as antipyretic and analgesic agent. This molecule exhibits two relevant conformers differing from one another in the orientation of the OH relatively to the carbonyl group [35]. In one of them the dihedral angle formed by the H-O(1)-C-O(2) atoms is close to 180° (

Figure 2.
Optimized geometry of the
3. Polymorphism
According to McCrone [36], polymorphism of a compound corresponds to its ability to crystallize into more than one crystalline structure. From the thermodynamic point of view, only the lowest Gibbs energy form exists. However, higher energy polymorphs can remain as metastable forms for a period of time long enough to be used for practical purposes, providing the height of the energy barrier separating these polymorphs and the most stable one is sufficiently high [28]. Since different solid-state modifications exhibit distinct physicochemical properties, such for example the melting point, solubility, dissolution rate and density, polymorphism has a great impact in the pharmaceutical, food and dyes technologies, among others. For example, in the pharmaceutical industry, the desired polymorph for a given active pharmaceutical ingredient (API) would be the one with highest bioavailability and structural stability during shelf life [37].

Figure 3.
Views of the crystalline structures of forms I (a) and II (b) of paracetamol and detail of the H-bonds formed in both polymorphs [(c) and (d)].
A typical example of a drug exhibiting polymorphism is paracetamol. Three polymorphs, labeled as I, II and III, have been identified for this compound [38-40]. The first (form I) is the thermodynamically stable form while the second (form II) is metastable but exists long enough to be experimentally studied. It is usually prepared from cooled melt [41]. Form III is very unstable [41] and thus it is not possible to investigate its structure and properties. Form I crystallizes in the monoclinic system (space group
The geometric parameters of the H-bonds in forms I and II are summarized in Table 1. In both forms the O–H‧‧‧O=C hydrogen bond is stronger than the N–H‧‧‧O–H one. In addition, the hydrogen bonds in the stable polymorph are stronger than in the metastable one.
The two polymorphs were also characterized by infrared spectroscopy [46, 47]. The values of the stretching vibration frequencies for the groups involved in hydrogen bonds are given in Table 2. To work as reference, the frequencies of the “free” groups, obtained from a spectrum of paracetamol in a CDCl3 solution were also included in the Table. From the frequency shift (Δν) of the NH and OH groups one can estimate the enthalpy involved in the two hydrogen bonds by applying the empirical relationship proposed by Iogansen: Δ
|
|
|||||
I | 1.719 | 2.653 | 167.5 | 2.032 | 2.904 | 161.6 |
II | 1.838 | 2.709 | 170.6 | 2.069 | 2.943 | 163.8 |
|
|
|
|
form I | 3324 | 3160 | 1656 |
form II | 3326 | 3205 | 1666 ; 1656 |
CDCl3 solution | 3438 | 3600 | 1683 |
The higher stability of form I is also confirmed by the thermodynamic properties obtained for sublimation, fusion and vaporization of the two polymorphic forms [38]. The value of the packing density, determined by flotation or X-ray (or neutron) diffraction [49] is higher in form II than in form I. In fact, at 298K the density of the former is 1.336 g cm-3 while that of the latter is 1.297 g cm-3. That is, the higher stability of form I results from a stronger hydrogen bond interaction rather than from a more favorable packing. In this compound, the differences between specific interactions resulting from the conformational recognition overcome that due to the crystal packing.
The polymorphism of paracetamol assumes great importance from the practical point of view in so far the commercialized polymorph is not the most suitable solid for formulation [45, 50, 51]. Despite it is easily obtained from various solvents, it has the inconvenient to require a binding agent to make tablets for compression. During this process it gives a brittle solid, consequence of its rough molecular layers. Conversely, form II is constituted by thin plates that glide on pressing. Its plasticity allows the formulation into tablets by direct compression without the need of incorporating any binder agent [45]. The main difficulty to obtain this form comes up against the existence of an adequate method for their preparation at an industrial scale [41].
Aspirin (acetylsalicylic acid) is a drug commonly used as analgesic, antipyretic and anti-inflammatory. It is also known to act as anticoagulant by reducing the blood platelet aggregation [52]. About 35,000 tons of aspirin are taken a day throughout the world.
Using X-ray diffraction, the structure of aspirin has been characterized for the first time in 1964 as a monoclinical crystal, space group P21/c [53]. In 2004, the existence of a second polymorph (form II) was predicted computationally [54] and observed experimentally one year later [55]. However, in view of the slight differences between both structural modifications, it was speculated that this new form might result from uncertainties of the methods used in the structural characterization [56, 57]. Just recently it has been settled the existence of a second polymorph for this compound [58]. In both forms, the carboxyl groups of two neighbor molecules are connected by O–H‧‧‧O=C H-bonds giving rise to centrosymmetric dimers as illustrated in Figure 4. These dimers are arranged into stacked layers, which are identical in the two polymorphs. The acetyl groups of molecules belonging to different layers are in turns interconnected through C–H‧‧‧O interactions. In Form I, these interactions have centrosymmetric geometry,

Figure 4.
H-bonds in the crystalline structures of forms I and II of aspirin.
An interesting feature of aspirin single crystals is that they exhibit simultaneously domains of forms I and II of variable relative size. Deran
Besides polymorphism, further crystalline structure complexity arises with the existence of disorder in crystals, situation quite common in many organic crystals [60-64]. This occurs when portions of the structure under analysis occupy two or more positions. For example, molecular fragments of organic molecules not involved in intermolecular interactions can be free enough to acquire different conformations. Such solids are designated by the conflicting denomination of disordered crystals. An example of a compound exhibiting crystal disorder is betaxolol hydrochloride, 1-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-3-isopropyl-amino-2-propanol hydrochloride (Figure 5). It is a cardio selective β adrenergic drug that crystallizes into the triclinic system with

Figure 5.
Conformations of betaxolol hydrochloride in the crystalline structure. Hydrogen bonds between the amino and hydroxyl groups with the chloride ion of the same molecule are represented by dotted lines. For better visualization the hydrogen atoms are not shown.
The intermolecular arrangement in the crystalline structure is as follows: the NH2+ and the OH groups of the isopropylaminoethanol moiety form H-bonds with the chloride ion of the same molecule as shown in Figure 5. In addition, one of the hydrogens of the NH2+ group is also H-bonded to oxygen atom of the OH group of a second molecule while the other hydrogen of the same group is linked to the chloride ion of a third molecule [63, 64]. That is, the betaxolol molecules are connected each other just through the isopropylaminoethanol fragment, leaving a long molecular chain free to move. The X-ray diffraction data shows the existence of an ordered head from the isopropyl group up to O2 and a disordered tail from this atom to the end. By refinement, the crystalline structure can be satisfactory interpreted as being constituted by two conformations which are displayed in Figure 5. Since we have a no well defined unit cell, the structure of betaxolol hydrochloride can not be included in the polymorphism or isomorphism definitions.
4. Erythritol and threitol: identical chemical structure, different crystalline assembling
Erythritol and

Figure 6.
DSC cooling curves of molten erythritol (m.p = 118°C) and
Conformationally, both diastereomers are highly flexible. In fact, the existence of seven independent dihedral angles, each of them assuming three standard orientations: gauche+ (60°), gauche– (-60°) and trans (180°), originate a total of 2187 possible conformers. Such a large number of structures make their systematic exploration by means of
The Boltzmann populations of the erythritol and
As shown in Figure 7, isolated erythritol exists preferentially in the

Figure 7.
Conformational distribution of erythritol and
Regarding
The results just presented provide an important basis to understand the different crystallization ability of erythritol and

Figure 8.
Most stable conformers of erythritol and
5. Conformational variation during the molecular incorporation into the crystal: Glutamic acid
Glutamic acid, 2-aminopentanedioic acid (C5H9NO4), is another example illustrating the role played by conformation on crystallization. Two conformational polymorphs have been identified for this compound, labeled as α and β, with the latter being the thermodynamically stable form over all temperature range [74-77]. The crystals have different morphologies: the metastable form exhibits a prismatic shape while the stable one has a needle-like shape. Both belong to the ortorrombic space group with four molecules in the unit cell (
The conformations adopted by the
The conformational behavior of zwitterionic glutamic acid is aqueous solution is a useful starting point to understand the crystallization of this compound in molecular terms. This has been done theoretically by performing full geometry optimizations using the CPCM continuum solvation model and the B3LYP/aug-cc-pVDZ model chemistry, both implemented in the Gaussian 03 program. The cavity was built with the Bondii radii which have been found to yield accurate results for the hydration of similar molecules in the zwitterionic state, such for example glycine [80]. Nine starting geometries were built by assuming the three standard orientations (

Figure 9.
CPCM/B3LYP/aug-cc-pVDZ optimized geometries of relevant conformers of the zwitterionic glutamic acid in aqueous solution. Dashed line represents an intramolecular hydrogen bond. Atom numbering scheme is shown for the most stable conformer.
The Gibbs energies of the conformers in aqueous solution at 298.15 K (
Regarding the two crystal conformations,
|
|
|
|
|||
|
|
|||||
|
178.5 | 75.3 | 13.1 | 184.8 | 0.0 | 67.1 |
|
168.9 | -177.2 | 56.9 | 223.7 | 3.9 | 13.6 |
|
-52.5 | -79.9 | 0.0 | 168.2 | 4.8 | 9.8 |
|
63.1 | 178.8 | 36.4 | 196.1 | 7.4 | 3.5 |
|
-56.5 | 178.7 | 52.1 | 213.7 | 7.7 | 3.0 |
|
172.5 | -69.8 | 59.6 | 221.9 | 8.4 | 2.3 |
|
62.4 | -85.1 | 49.8 | 208.1 | 12.5 | 0.4 |
|
66.1 | 61.1 | 54.7 | 210.5 | 14.0 | 0.2 |
|
-61.7 | 81.4 | 71.1 | 225.3 | 18.3 | 0.0 |
Table 3.
Dihedral angles, intrinsic electronic energies at 0K (
6. Molecular dynamics study of pre-nucleation clusters
The molecular aggregates individualized in the early stages of nucleation (pre-nucleation) are windows to follow the crystallization process. Data on the self-assembly of erythritol and
Useful data about the type of aggregates formed in solution can be given by the RDFs for the different pairs of solute OH groups (OH–OH) which are depicted in Figure 10. They were obtained from the simulation of an aqueous solution containing 11 solute molecules and 4000 solvent molecules, corresponding to a concentration of 75g /100 cm3, which is near to the saturation concentration [84].

Figure 10.
OH–OH RDFs for erythritol and
In erythritol, the most prominent RDFs are found for the O(2)H–O(3)H and O(1)H–O(4)H pairs. Both RDFs, labeled in Figure 10 as c1 and c2, respectively, exhibit sharp and intense peaks at
Regarding

Figure 11.
Snapshots of the erythritol clusters formed in aqueous solution.

Figure 12.
Snapshots of the
7. Conclusion
Structural aspects of crystallization from solvents were pointed out throughout this chapter. Particular attention was paid to the conformational variation of flexible molecules during this process. Three compounds were taken as examples: erythritol,
The investigation of the structure of the molecular aggregates formed in solution by molecular dynamics, here exemplified for erythritol and
Polymorphism, an important property of the solid state structure with various practical implications, was called in the present chapter as a tangly pathway in the crystallization process. Additional crystalline structure complexity may result from crystal disorder, hardly to be included in the polymorphism concept.
References
- 1.
Brian Henderson and Ralph HB. Crystal-Field Engineering of Solid-State Laser Materials. New York: Cambridge University Press; 2000. - 2.
Brooks JS. Organic crystals: properties, devices, functionalization and bridges to bio-molecules. Chemical Society Reviews. 2010;39(7):2667-94. - 3.
Day GM, Motherwell WDS, Ammon HL, Boerrigter SXM, Della Valle RG, Venuti E, et al. A third blind test of crystal structure prediction. Acta Crystallographica Section B. 2005;61(5):511-27. - 4.
Motherwell WDS, Ammon HL, Dunitz JD, Dzyabchenko A, Erk P, Gavezzotti A, et al. Crystal structure prediction of small organic molecules: a second blind test. Acta Crystallographica Section B. 2002;58(4):647-61. - 5.
Lommerse JPM, Motherwell WDS, Ammon HL, Dunitz JD, Gavezzotti A, Hofmann DWM, et al. A test of crystal structure prediction of small organic molecules. Acta Crystallographica Section B. 2000;56(4):697-714. - 6.
Oganov AR, editor. Modern Methods of Crystal Structure Predictions. Weinheim: Wiley-VCH; 2011. - 7.
Woodley SM, Catlow R. Crystal structure prediction from first principles. Nature Materials. 2008;7(12):937-46. - 8.
Oganov AR, Glass CW. Crystal structure prediction using ab initio evolutionary techniques: Principles and applications. Journal of Chemical Physics. 2006;124(24):244704-15. - 9.
Day GM, Cooper TG, Cruz-Cabeza AJ, Hejczyk KE, Ammon HL, Boerrigter SXM, et al. Significant progress in predicting the crystal structures of small organic molecules - a report on the fourth blind test. Acta Crystallographica Section B. 2009;65(2):107-25. - 10.
Kim S, Orendt AM, Ferraro MB, Facelli JC. Crystal structure prediction of flexible molecules using parallel genetic algorithms with a standard force field. Journal of Computational Chemistry. 2009;30(13):1973-85. - 11.
Day GM, S. Motherwell WD, Jones W. A strategy for predicting the crystal structures of flexible molecules: the polymorphism of phenobarbital. Physical Chemistry Chemical Physics. 2007;9(14):1693-704. - 12.
Hohenberg P, Kohn W. Inhomogeneous Electron Gas. Physical Review. 1964;136(3B):B864-B71. - 13.
Kohn W, Sham LJ. Self-Consistent Equations Including Exchange and Correlation Effects. Physical Review. 1965;140(4A):A1133-A8. - 14.
Becke AD. Density-Functional Exchange-Energy Approximation with Correct Asymptotic-Behavior. Physical Review A. 1988 Sep 15;38(6):3098-100. - 15.
Becke AD. Density-Functional Thermochemistry.3. The Role of Exact Exchange. Journal of Chemical Physics. 1993 Apr 1;98(7):5648-52. - 16.
Lee CT, Yang WT, Parr RG. Development of the Colle-Salvetti Correlation-Energy Formula into a Functional of the Electron-Density. Physical Review B. 1988 Jan 15;37(2):785-9. - 17.
Dunning J, Thom H. Gaussian basis sets for use in correlated molecular calculations. I. The atoms boron through neon and hydrogen. Journal of Chemical Physics. 1989 1989/01/15/;90(2):1007-23. - 18.
Woon DE, Dunning J, Thom H. Gaussian basis sets for use in correlated molecular calculations. III. The atoms aluminum through argon. Journal of Chemical Physics. 1993 1993/01/15/;98(2):1358-71. - 19.
Krishnan R, Binkley JS, Seeger R, Pople JA. Self-consistent molecular orbital methods. XX. A basis set for correlated wave functions. Journal of Chemical Physics. 1980;72(1):650-4. - 20.
Cossi M, Rega N, Scalmani G, Barone V. Energies, structures, and electronic properties of molecules in solution with the C-PCM solvation model. Journal of Computational Chemistry. 2003 Apr 30;24(6):669-81. - 21.
Cossi M, Barone V, Cammi R, Tomasi J. Ab initio study of solvated molecules: A new implementation of the polarizable continuum model. Chemical Physics Letters. 1996 Jun 14;255(4-6):327-35. - 22.
Klamt A, Schuurmann G. Cosmo - a New Approach to Dielectric Screening in Solvents with Explicit Expressions for the Screening Energy and Its Gradient. Journal of the Chemical Society- Perkin Transactions 2. 1993(5):799-805. - 23.
Weissbuch I, Kuzmenko I, Vaida M, Zait S, Leiserowitz L, Lahav M. Twinned Crystals of Enantiomorphous Morphology of Racemic Alanine Induced by Optically Resolved.alpha.-Amino Acids; A Stereochemical Probe for the Early Stages of Crystal Nucleation. Chemistry of Materials. 1994 2012/09/14;6(8):1258-68. - 24.
Etter MC. Hydrogen bonds as design elements in organic chemistry. Journal of Physical Chemistry. 1991 2012/09/14;95(12):4601-10. - 25.
Weissbuch I, Lahav M, Leiserowitz L. Toward Stereochemical Control, Monitoring, and Understanding of Crystal Nucleation. Crystal Growth & Design. 2003 2012/09/14;3(2):125-50. - 26.
Bernstein J. Polymorphism in Molecular Crystals. Oxford: Oxford University Press; 2002. - 27.
Hilfiker R, editor. Polymorphism in the Pharmaceutical Industry. Weinheim: Willey-VCH; 2006. - 28.
Brittain HG, editor. Polymorphism in Pharmaceutical Solids. 2 ed. New York: Informa Healthcare USA, Inc; 2009. - 29.
Nangia A. Conformational Polymorphism in Organic Crystals. Accounts of Chemical Research. 2008;41(5):595-604. - 30.
J.W.Mullin. Crystallization. 4 ed. Oxford: Butterworth-Heinemann; 2001. - 31.
Schmelzer JWP, editor. Nucleation Theory and Applications: WILEY-VCH; 2005. - 32.
Laaksonen A, Talanquer V, Oxtoby DW. Nucleation: Measurements, Theory, and Atmospheric Applications. Annual Review of Physical Chemistry. 1995;46(1):489-524. - 33.
Steiner T. The hydrogen bond in the solid state. Angewandte Chemie, International Edition in English. 2002;41(1):48-76. - 34.
Elangannan Arunan, Gautam R. Desiraju, Roger A. Klein, Joanna Sadlej, Steve Scheiner, Ibon Alkorta, et al. Definition of the hydrogen bond (IUPAC Recommendations 2011). Pure and applied chemistry. 2011;83(8):1637-41. - 35.
Lee SJ, Min A, Kim Y, Ahn A, Chang J, Lee SH, et al. Conformationally resolved structures of jet-cooled acetaminophen by UV-UV hole-burning spectroscopy. Physical Chemistry Chemical Physics. 2011;13(37):16537-41. - 36.
McCrone WC. In: Fox D, Labes MM, Weissberger A, editors. Physics and Chemistry of the Organic Solid State. London: Interscience Publishers; 1965. p. 725-67. - 37.
Singhal D, Curatolo W. Drug polymorphism and dosage form design: a practical perspective. Advanced Drug Delivery Reviews. 2004;56(3):335-47. - 38.
Perlovich G, Volkova T, Bauer-Brandl A. Polymorphism of paracetamol. Journal of Thermal Analysis and Calorimetry. 2007;89(3):767-74. - 39.
Kolesov BA, Mikhailenko MA, Boldyreva EV. Dynamics of the intermolecular hydrogen bonds in the polymorphs of paracetamol in relation to crystal packing and conformational transitions: a variable-temperature polarized Raman spectroscopy study. Physical Chemistry Chemical Physics. 2011;13(31):14243-53. - 40.
Boldyreva E, Drebushchak V, Paukov I, Kovalevskaya Y, Drebushchak T. DSC and adiabatic calorimetry study of the polymorphs of paracetamol. Journal of Thermal Analysis and Calorimetry. 2004;77(2):607-23. - 41.
Di Martino P, Conflant P, Drache M, Huvenne JP, Guyot-Hermann AM. Preparation and physical characterization of forms II and III of paracetamol. Journal of Thermal Analysis and Calorimetry. 1997;48(3):447-58. - 42.
Haisa M, Kashino S, Kawai R, Maeda H. The Monoclinic Form of p-Hydroxyacetanilide. Acta Crystallographica Section B-Structural Science. 1976;32(4):1283-5. - 43.
Bouhmaida N, Bonhomme F, Guillot B, Jelsch C, Ghermani NE. Charge density and electrostatic potential analyses in paracetamol. Acta Crystallographica Section B. 2009;65(3):363-74. - 44.
Haisa M, Kashino S, Maeda H. The orthorhombic form of p-hydroxyacetanilide. Acta Crystallographica Section B. 1974;30(10):2510-2. - 45.
Nichols G, Frampton CS. Physicochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution. Journal of Pharmaceutical Sciences. 1998;87(6):684-93. - 46.
Burgina EB, Baltakhinov VP, Boldyreva EV, Shakhtschneider TP. IR Spectra of Paracetamol and Phenacetin. 1. Theoretical and Experimental Studies. Journal of Structural Chemistry. 2004;45(1):64-73. - 47.
Ivanova BB. Monoclinic and orthorhombic polymorphs of paracetamol - solid state linear dichroic infrared spectral analysis. Journal of Molecular Structure. 2005;738(1-3):233-8. - 48.
Iogansen AV. Direct proportionality of the hydrogen bonding energy and the intensification of the stretching v(XH) vibration in infrared spectra. Spectrochimica Acta, Part A: Molecular and Biomolecular Spectroscopy. 1999;55(7-8):1585-612. - 49.
Wendy C. Duncan-Hewitt, Grant DJW. True density and thermal expansivity of pharmaceutical solids: comparison of methods and assessment of crystallinity. International Journal of Pharmaceutics. 1986;28(1):75-84. - 50.
Joiris E, Martino PD, Berneron C, Guyot-Hermann A-M, Guyot J-C. Compression Behavior of Orthorhombic Paracetamol. Pharmaceutical Research. 1998;15(7):1122-30. - 51.
Di Martino P, Guyot-Hermann AM, Conflant P, Drache M, Guyot JC. A new pure paracetamol for direct compression: The orthorhombic form. International Journal of Pharmaceutics. 1996;128:1-8. - 52.
Roth GJ, Calverley DC. Aspirin, Platelets, and Thrombosis: Theory and Practice. Blood. 1994;83(4):885-98. - 53.
Wheatley PJ. The crystal and molecular structure of aspirin. Journal of the Chemical Society (Resumed). 1964:6036-48. - 54.
Ouvrard C, Price SL. Toward Crystal Structure Prediction for Conformationally Flexible Molecules: The Headaches Illustrated by Aspirin. Crystal Growth & Design. 2004;4(6):1119-27. - 55.
Vishweshwar P, McMahon JA, Oliveira M, Peterson ML, Zaworotko MJ. The Predictably Elusive Form II of Aspirin. Journal of the American Chemical Society. 2005 2012/09/10;127(48):16802-3. - 56.
Bond AD, Boese R, Desiraju GR. On the Polymorphism of Aspirin. Angewandte Chemie International Edition. 2007;46(4):615-7. - 57.
Chang C-J, Díaz LE, Morin F, Grant DM. Solid-state 13C NMR study of drugs: Aspirin. Magnetic Resonance in Chemistry. 1986;24(9):768-71. - 58.
Wen S, Beran GJO. Accidental Degeneracy in Crystalline Aspirin: New Insights from High-Level ab Initio Calculations. Crystal Growth & Design. 2012 2012/09/10;12(5):2169-72. - 59.
Bond AD, Boese R, Desiraju GR. What Is A Polymorph? Aspirin As A Case Study. American Pharmaceutical Review. 2007:1-4. - 60.
Glusker JP, Lewis M, Rossi M. Crystal Structure Analysis for Chemists and Biologists (Methods in Stereochemical Analysis). New York: Wiley-VCH; 1994. - 61.
Wilson CC. A basic introduction to thermal motions of atoms in crystal structures, the underlying potentials and the physical information available from their analysis. Crystallography Reviews. 2009 2012/09/11;15(1):3-56. - 62.
Habgood M, Grau-Crespo R, Price SL. Substitutional and orientational disorder in organic crystals: a symmetry-adapted ensemble model. Physical Chemistry Chemical Physics. 2011;13(20):9590-600. - 63.
Redinha JS, Lopes Jesus AJ. Molecular Recognition and Crystal Growth. In: McEvoy JA, editor. Molecular Recognition: Biotechnology, Chemical Engineering and Materials Applications: Novapublishers; 2011. - 64.
Redinha JS, Lopes Jesus AJ. Crystal Growth of Pharmaceuticals from Melt. In: Borisenko E, editor. Crystallization and material science of modern artificial and natural crystals. Rijeka: InTech; 2012. - 65.
Pascard C, Tran Huu Dau E, Manoury P, Mompon B. Betaxolol hydrochloride: 1-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-3-isopropylamino-2-propanol hydrochloride, C18H30NO3+.Cl. Acta Crystallographica, Section C: Crystal Structure Communications. 1984;40(8):1430-2. - 66.
Lopes Jesus AJ, Nunes SCC, Ramos Silva M, Matos Beja A, Redinha JS. Erythritol: Crystal growth from the melt. International Journal of Pharmaceutics. 2010;388(1-2):129-35. - 67.
Lopes Jesus AJ, Redinha JS. On the structure of erythritol and L-threitol in the solid state: An infrared spectroscopic study. Journal of Molecular Structure. 2009;938(1-3):156-64. - 68.
Yu L, Reutzel-Edens SM, Mitchell CA. Crystallization and Polymorphism of Conformationally Flexible Molecules: Problems, Patterns, and Strategies. Organic Process Research & Development. 2000 2012/09/14;4(5):396-402. - 69.
Lopes Jesus AJ, Tomé LIN, Rosado MTS, Leitão MLP, Redinha JS. Conformational study of erythritol and threitol in the gas state by density functional theory calculations. Carbohydrate Research. 2005;340(2):283-91. - 70.
Lopes Jesus AL, Tomé LIN, Eusébio MES, Redinha JS. Determination of the Enthalpy of Solute-Solvent Interaction from the Enthalpy of Solution: Aqueous Solutions of Erythritol and L-Threitol. Journal of Physical Chemistry B. 2006 May 11, 2006;110(18):9280-5. - 71.
Ceccarelli C, Jeffrey GA, McMullan RK. A Neutron-Diffraction Refinement of the Crystal-Structure of Erythritol at 22.6 K. Acta Crystallographica Section B. 1980;36:3079-83. - 72.
Kopf J, Morf M, Zimmer B, Haupt ETK, Jarchow O, Köll P. The crystal and molecular structure of threitol. Carbohydrate Research. 1993;247:119-28. - 73.
Jeffrey GA, Kim HS. Conformations of the alditols. Carbohydrate Research. 1970;14(2):207-16. - 74.
Kitamura M. Polymorphism in the crystallization of L-glutamic acid. Journal of Crystal Growth. 1989;96(3):541-6. - 75.
Kitamura M. Controlling factor of polymorphism in crystallization process. Journal of Crystal Growth. 2002;237-239:2205-14. - 76.
Davey RJ, Blagden N, Potts GD, Docherty R. Polymorphism in Molecular Crystals: Stabilization of a Metastable Form by Conformational Mimicry. Journal of the American Chemical Society. 1997;119(7):1767-72. - 77.
Ono T, ter Horst JH, Jansens PJ. Quantitative Measurement of the Polymorphic Transformation of l-Glutamic Acid Using In-Situ Raman Spectroscopy. Crystal Growth & Design. 2004;4(3):465-9. - 78.
Lehmann M, Koetzle T, Hamilton W. Precision neutron diffraction structure determination of protein and nucleic acid components. VII. The crystal and molecular structure of the amino acid L-lysine monohydrochloride dihydrate. Journal of Chemical Crystallography. 1972;2(5):225-33. - 79.
Lehmann MS, Nunes AC. A short hydrogen bond between near identical carboxyl groups in the [alpha]-modification of l-glutamic acid. Acta Crystallographica, Section B: Structural Science. 1980;36(7):1621-5. - 80.
Kim CK, Park B-H, Lee HW, Kim CK. Comprehensive Studies on the Free Energies of Solvation and Conformers of Glycine: A Theoretical Study. Bulletin of the Korean Chemical Society. 2011;32(6):1985 - 92. - 81.
Peng CY, Ayala PY, Schlegel HB, Frisch MJ. Using redundant internal coordinates to optimize equilibrium geometries and transition states. Journal of Computational Chemistry. 1996;17(1):49-56. - 82.
Hess B, Kutzner C, van der Spoel D, Lindahl E. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. Journal of Chemical Theory and Computation. 2008;4(3):435-47. - 83.
Schuttelkopf AW, van Aalten DMF. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica Section D. 2004;60(8):1355-63. - 84.
Cohen S, Marcus Y, Migron Y, Dikstein S, Shafran A. Water sorption, binding and solubility of polyols. Journal of the Chemical Society, Faraday Transactions. 1993;89(17):3271-5. - 85.
Gilli G, Gilli P. Towards an unified hydrogen-bond theory. Journal of Molecular Structure. 2000;552(1-3):1-15.